Evidence map›Paper›PMID 10606271›Full record

ArticleRNA (New York, N.Y.)1999

In vitro selection identifies key determinants for loop-loop interactions: RNA aptamers selective for the TAR RNA element of HIV-1.

F Ducongé, J J Toulmé

Abstract read
In one paragraph

Article in RNA (New York, N.Y.), 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Aptamers against pathogenic microorganisms.Critical reviews in microbiology · 2016
    Review
  12. Article
  13. Specific Inhibition of MicroRNA Processing Using L-RNA Aptamers.Journal of the American Chemical Society · 2015
    Article
  14. Fitness Landscapes of Functional RNAs.Life (Basel, Switzerland) · 2015
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Binding of a structured D-RNA molecule by an L-RNA aptamer.Journal of the American Chemical Society · 2013
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

F DucongéInstitut National de la Santé et de la Recherche Médicale U 386, IFR Pathologies Infectieuses, Université Victor Segalen, Bordeaux, France.
J J Toulmé

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We selected RNA aptamers specific for the trans-activation responsive (TAR) RNA, a stem-loop structure crucial for the transcription of the integrated genome of the human immunodeficiency virus. Most of the selected sequences could be folded as imperfect hairpins and displayed a 5'-GUCCCAGA-3' consensus motif constituting the apical loop. The six central bases of this consensus sequence are complementary to the entire TAR loop, leading to the formation of TAR RNA-aptamer "kissing" complexes. The consensus G and A residues closing the aptamer loop contributed to the high affinity (Kd = 30 nM at 23 degrees C) of the aptamers for the TAR RNA. This G A pair was shown to be crucial for binding to TAR at a low magnesium concentration. The selection also identified 5'-PuPy and 5'-PyPu base pairs at alpha and beta positions of the stem, next to the loop, respectively. This strategy offered a way to identify key determinants of loop-loop interactions and to generate high affinity ligands of TAR RNA structure.

Indexed as

Nucleic Acid ConformationBase PairingBase SequenceBinding SitesConsensus SequenceDNA PrimersHIV-1HIV Long Terminal RepeatHumansKineticsMolecular Sequence DataOligoribonucleotidesPolymerase Chain ReactionRNA, ViralStructure-Activity RelationshipDNA PrimersOligoribonucleotidesRNA, Viral

Identifiers

PMID10606271
PMCPMC1369882

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.